MaxCyte, Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/68d0f321-c44f-4641-a441-c821b836bd6b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $21.0M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-034557 |
| FY 2024 | $22.2M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002721 |
| FY 2023 | $19.5M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-003001 |
| FY 2022 | $28.7M | 2022-01-01 – 2022-12-31 | evidence 0001558370-24-003001 |
| FY 2021 | $21.6M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004081 |
| FY 2020 | $15.5M | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-004081 |
| FY 2019 | $13.3M | 2019-01-01 – 2019-12-31 | evidence 0001558370-22-004081 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).